Ran Nussbaum's Net Worth
-$28.3 Thousand
Who is Ran Nussbaum?
Ran Nussbaum does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kite Pharma, Inc., Keros Therapeutics, Inc., VBI Vaccines Inc/BC, Prevail Therapeutics Inc., UroGen Pharma Ltd., Eloxx Pharmaceuticals, Inc., Arno Therapeutics, Inc, and ARQULE INC.
SEC CIK
Ran Nussbaum's CIK is 0001609805
Past Insider Trading and Trends
2019 was Ran Nussbaum's most active year for acquiring shares with 4 total transactions. Ran Nussbaum's most active month to acquire stocks was the month of May. 2017 was Ran Nussbaum's most active year for disposing of shares, totalling 5 transactions. Ran Nussbaum's most active month to dispose stocks was the month of September. 2018 saw Ran Nussbaum paying a total of $28,330.19 for 68,611 shares, this is the most they've acquired in one year. In 2017 Ran Nussbaum cashed out on 80,170 shares for a total of $11,826,349.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arno Therapeutics, Inc No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kite Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.19K |
—
|
—
|
0
|
Oct 3
| |||
Form 4
| +123.59% | 2.41K |
—
|
—
| 4.36K |
Jun 20
| |||
Form 4
|
∞
| 9.83K |
$69.11 | $679,474.08 | 9.83K |
May 9
| |||
Form 4
|
∞
| 1.95K |
—
|
—
| 1.95K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -100.00% | -305.43K |
$55.35 | -$16,906,458.74 |
0
|
Scheduled
|
Jun 1 - Jun 2
| ||
Form 4
| -21.03% | -193.73K |
$60.57 | -$11,710,488.29 | 727.56K |
Mar 27 - Mar 30
| |||
Form 4
|
∞
| 2.2M |
—
|
—
| 2.2M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -0.15% | -7.18K |
—
| -$0.71 | 4.63M |
Nov 29
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +1.27% | 60K |
$50.00 | $3,000,000.00 | 4.79M |
Nov 17
| |||
Form 4
| +31.88% | 3.98M |
$16.00 | $6,999,984.00 | 16.48M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VBI Vaccines Inc/BC (VBIV) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prevail Therapeutics Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.58M |
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||